Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers’ hands

Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers’ hands

February 6, 2026 discoverhiddenusacom Business

Novo Nordisk launched its first commercial during the big game, introducing the newly available Wegovy® pill – the first and only oral GLP-1 medication approved for weight loss in the United States. The ad campaign, featuring a diverse cast including Kenan Thompson, DJ Khaled, Danielle Brooks, Ana Gasteyer, John C. Reilly and Danny Trejo, aims to spark a broader conversation about weight management and challenge existing perceptions.

A New Approach to Weight Loss

The Wegovy® pill is indicated for adults with obesity, or those with overweight who also have weight-related medical problems, and is intended to be used alongside a reduced-calorie diet and increased physical activity. Novo Nordisk’s marketing emphasizes that the medication isn’t a shortcut, but rather a tool to support individuals in achieving their health goals. Ed Cinca, senior vice president of Marketing & Patient Solutions at Novo Nordisk, stated the company aims to “cut through clutter and start honest conversations about weight for people who want to take a step toward better health.”

Did You Know? The FDA approval of Wegovy® pill was based on a 64-week clinical trial involving 307 adults, demonstrating an average weight loss of approximately 14% for those taking the medication alongside diet and exercise, compared to 2.4% with a placebo.

Clinical Trial Results

Results from the OASIS 4 phase 3 clinical trial showed that individuals taking Wegovy® pill daily, in conjunction with a reduced-calorie diet and exercise, experienced an average weight loss of 13.6% versus 2.4% for those receiving a placebo. If all patients remained on treatment, the average weight loss increased to 17% with Wegovy® pill, compared to 2.7% with the placebo. Notably, 76% of participants taking the medication achieved at least 5% body weight loss.

Accessibility and Affordability

Wegovy® pill is now widely available at over 70,000 pharmacies across the US, including CVS and Costco, as well as through telehealth providers like Ro, LifeMD, and Weight Watchers. The starting dose (1.5 mg) is priced at $149 per month, or $5 per day, through a self-pay offer. More than 55 million Americans currently have insurance coverage for FDA-approved obesity medications, with some patients with commercial insurance potentially paying as little as $25 per month with the Wegovy® savings offer.

Expert Insight: The strategic timing of this launch, coinciding with a major media event like the big game, signals Novo Nordisk’s intent to directly engage consumers and normalize conversations around weight management, potentially broadening the adoption of this new treatment option.

DJ Khaled, featured in the ad campaign, shared his personal experience, stating, “I know what it’s like to go hard in the gym…but still not see the results you want.” He emphasized the potential of Wegovy® pill as a powerful option for those seeking additional support in reaching their health goals.

What’s Next?

The widespread availability of an oral weight loss medication could lead to increased demand and further discussion among healthcare providers and patients. Novo Nordisk’s focus on expanding access and affordability suggests a commitment to making Wegovy® pill accessible to a broader population. Continued monitoring of real-world outcomes and potential long-term effects will be crucial as more individuals begin using the medication.

Frequently Asked Questions

What is Wegovy® pill used for?

Wegovy® pill is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with excess weight who also have weight-related medical problems, lose weight and keep the weight off. It’s also indicated to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease.

Are there any serious side effects associated with Wegovy® pill?

Wegovy® pill may cause serious side effects, including possible thyroid tumors (including cancer), pancreatitis, gallbladder problems, and low blood sugar, especially in those also taking diabetes medications. It is important to discuss potential risks with a healthcare provider.

Where can I find more information about Wegovy® pill?

More information about Wegovy® pill, including prescribing information and cost/coverage details, can be found at www.Wegovy.com.

As Wegovy® pill enters the market, how might this new option reshape the landscape of weight management and conversations surrounding health and wellness?